OCS (Oculis Holding AG) 1-Year Share Buyback Ratio: -32.80% (As of Jun. 2026 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OCS Oculis Holding AG OCS
22 GF Score
Price $12.12
! 1 Warning Sign
View Full Analysis

What is Oculis Holding AG 1-Year Share Buyback Ratio?

Oculis Holding AG OCS -1.34% 22 1-Year Share Buyback Ratio is -32.80 as of Jun. 2026. GuruFocus rates OCS with a GF Score™ of 22/100. The stock has 1 warning sign investors should review. Among 1,106 Biotechnology companies, Oculis Holding AG ranks worse than 68.26% on this metric.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Oculis Holding AG's current 1-Year Share Buyback Ratio was -32.80%.

OCS's 1-Year Share Buyback Ratio is ranked worse than
68.26% of 1106 companies
in the Biotechnology industry
Industry Median: -14.6 vs OCS: -32.80

Oculis Holding AG  (NAS:OCS) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Oculis Holding AG 1-Year Share Buyback Ratio Related Terms

OCS vs ZVRA, ASMB, ALLO: 1-Year Share Buyback Ratio Comparison

For the Biotechnology subindustry, Oculis Holding AG's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oculis Holding AG 1-Year Share Buyback Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oculis Holding AG's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Oculis Holding AG's 1-Year Share Buyback Ratio falls into.


OCS
22GF Score
Oculis Holding AG OCS
1-Year Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oculis Holding AG 1-Year Share Buyback Ratio Calculation

Oculis Holding AG's 1-Year Share Buyback Ratio for the quarter that ended in Jun. 2026 is calculated as

1-Year Share Buyback Ratio=(Shares Outstanding (EOP) (Jun. 2025 ) - Shares Outstanding (EOP) (Jun. 2026 )) / Shares Outstanding (EOP) (Jun. 2025 )
=(52.336 - 55.528) / 52.336
=-6.1%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a 1-Year Share Buyback Ratio of -32.80 mean?
Oculis Holding AG (OCS) has a 1-Year Share Buyback Ratio of -32.80 as of Jun. 2026. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Oculis Holding AG and its competitors. According to the industry distribution chart, Oculis Holding AG ranks #755 out of 1106 companies in the Biotechnology industry, placing it in the top 68.3%.
Is Oculis Holding AG's 1-Year Share Buyback Ratio too high?
Oculis Holding AG's current 1-Year Share Buyback Ratio is -32.80. Based on the distribution chart, Oculis Holding AG ranks #755 out of 1106 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Oculis Holding AG has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Oculis Holding AG's 1-Year Share Buyback Ratio compare to ZVRA and ASMB?
According to the Biotechnology industry distribution chart, Oculis Holding AG ranks #755 out of 1106 companies for 1-Year Share Buyback Ratio. This places Oculis Holding AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Share Buyback Ratio for a Biotechnology company?
A good 1-Year Share Buyback Ratio depends on the Biotechnology industry context. However, 1-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Share Buyback Ratio mean?
A high 1-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Oculis Holding AG and its competitors. Oculis Holding AG's current 1-Year Share Buyback Ratio is -32.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oculis Holding AG stock overvalued right now?
Oculis Holding AG (OCS) has a current 1-Year Share Buyback Ratio of -32.80. The current 1-Year Share Buyback Ratio is -32.80. Oculis Holding AG's overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Share Buyback Ratio calculated?
1-Year Share Buyback Ratio is calculated from a company's financial statements. For Oculis Holding AG (OCS), the current 1-Year Share Buyback Ratio is -32.80 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oculis Holding AG Business Description

Other Exchanges OCS:IcelandCR5:Germany
Address Bahnhofstrasse 20, Zug, CHE, CH-6300
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
22GF Score

Get the complete analysis for OCS

1-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.12
Price